Hanwha Solutions Initiates Business Restructuring, Withdraws New Investment and Plans U.S. Asset Sale

Reporter Kim Jisun / approved : 2025-11-26 03:05:12
  • -
  • +
  • 인쇄

Photo courtesy of Hanwha Solutions

 

 

[Alpha Biz= Paul Lee] Hanwha Solutions has begun a major restructuring of its business portfolio, withdrawing from a planned new investment and deciding to divest its stake in a U.S.-based investment company. The move is seen as an effort to improve financial stability by removing risk factors associated with new business ventures amid a challenging market environment.


On the 24th, Hanwha Solutions announced that it would cancel its planned investment in a high-purity cresol production facility. The company explained that the project had lost economic viability due to longer-than-expected development timelines, increased capital requirements, and rising global supply from China and India, which has pushed down cresol prices since the project was first reviewed.


High-purity cresol is a key raw material used in healthcare products, plastic additives, and synthetic fragrances. Hanwha Solutions had positioned it as a high value-added growth business and began investing in 2021, with plans to complete facilities by 2023. However, delays in mass-production readiness hindered progress. The company had planned to invest a total of KRW 223 billion by the end of this year and is now exploring ways to minimize losses.


Hanwha Solutions has faced a difficult operating environment, alternating between quarterly profits and losses. Its core petrochemical business continues to suffer from China-driven oversupply, while the renewable energy division—including solar—has been hit by U.S. trade policies. Although U.S. restrictions on Chinese solar imports are beneficial in theory, stricter customs procedures have slowed shipments, causing third-quarter sales to decline about 10% from the previous quarter. A return to losses is anticipated in Q4.


Alongside the investment withdrawal, Hanwha Solutions will also sell its stake in Hanwha Futureproof, a U.S.-based group investment company. The total disposal amount is KRW 1.1407 trillion, of which KRW 285.3 billion will be reinvested, leaving approximately KRW 855.4 billion in net cash inflows. While the company has not yet specified how the funds will be used, they are expected to support balance sheet strengthening and overall financial improvement.

 

 

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Heungkuk Securities Lowers Target Price on Lotte Holdings, Citing Weak Performance at Lotte Chemical2025.12.18
Hyundai Motor Group to Reshuffle Top Management; Hyundai Steel CEO Seo Gang-hyun to Return to Group Control Tower2025.12.18
LG Energy Solution Hit by Prolonged EV Demand Slump as Ford Terminates Long-Term Battery Supply Contract2025.12.18
NCSoft Files Lawsuit Against YouTube Channel Operator Over Alleged False Claims on Aion 22025.12.18
Daewoo Engineering & Construction Ordered to Suspend Civil and Building Construction Business for Two Months2025.12.18
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사